Olmesartan Medoxomil

Images are for illustration purposes only;
actual packaging may vary.

Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) commonly used in the management of hypertension. By inhibiting the action of angiotensin II, it effectively relaxes blood vessels, leading to a reduction in blood pressure and improved cardiovascular health.

This API is particularly beneficial for patients who require a tailored approach to blood pressure management, as it can be compounded into various formulations to meet specific patient needs. Its efficacy in lowering blood pressure makes it a valuable option for prescribers aiming to reduce the risk of stroke and heart attack in hypertensive patients.

Trusted by 60,357 patients to date.

A group of faces of our past satisfied patients.

Custom made in our compounding labs.

Personalized treatment for better results.

All strengths and ingredients are tailored to your needs.

This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.

This is some text inside of a div block.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5

Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

Item 1
Item 2
Item 3

Unordered list

Item A
Item B
Item C

Text link

Bold text

Emphasis

^Superscript

_Subscript

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Active Ingredient Information

Olmesartan Medoxomil is a potent antihypertensive agent belonging to the class of angiotensin II receptor blockers (ARBs). It is primarily used to manage high blood pressure, thereby reducing the risk of cardiovascular events such as strokes and heart attacks. By selectively blocking the binding of angiotensin II to the AT1 receptor, Olmesartan Medoxomil effectively relaxes blood vessels, leading to a decrease in blood pressure.

This API is well-regarded for its efficacy in providing 24-hour blood pressure control with once-daily dosing, making it a convenient option for patients. Olmesartan Medoxomil is often considered for patients who require a tailored approach to hypertension management, especially those who may not respond adequately to other antihypertensive medications.

In addition to its primary use, Olmesartan Medoxomil has been studied for its potential benefits in protecting renal function, particularly in patients with type 2 diabetes and hypertension. Its favorable safety profile and minimal side effects make it a preferred choice among healthcare providers.

When prescribing Olmesartan Medoxomil, it is important for healthcare professionals to consider potential drug interactions and contraindications, such as its use in pregnant patients. Regular monitoring of blood pressure and renal function is recommended to ensure optimal therapeutic outcomes.

Formulas using

Olmesartan Medoxomil

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.